Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 299.50
+10.50 (3.63%)
Oct 17, 2025, 2:38 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 78.76 billion as of October 17, 2025. Its market cap has increased by 9.66% in one year.
Market Cap
78.76B
Enterprise Value
86.27B
Revenue
19.12B
Ranking
n/a
PE Ratio
16.20
Stock Price
299.50
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 78.76B, an increase of 757.29%. That is a compound annual growth rate of 21.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 78.76B | 10.12% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | 19.63B | -29.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 251.26B |
| PharmaEssentia | 190.83B |
| Bora Pharmaceuticals Co., LTD. | 80.18B |
| Lumosa Therapeutics | 48.85B |
| Oneness Biotech | 30.37B |
| Polaris Group | 27.74B |
| Center Laboratories | 25.27B |
| Pegavision | 23.83B |